Infectious Thoughts Interview: Dr. Benny Baeten (Johnson & Johnson)

October 1, 2017

 

 

 

Dr. Benny Baeten, Compound Development Team Leader for Anthelminthics at the Janssen Pharmaceutical Companies of Johnson & Johnson speaks to the ISNTD about current research at J&J on antihelmintihcs and the future partnerships at Janssen for NTDs.

Recorded at ISNTD d³ on May 16th 2017 at the Wellcome Trust London.

…………………………………………………….

For more information please contact:

 

Kamran Rafiq 

krafiq@isntd.org

 

 

Share on Facebook
Share on Twitter
Please reload

Featured Interviews

Assessing the repellent efficacy of essential oils

October 31, 2019

1/10
Please reload

Recent Interviews
Please reload

Search By Tags